SBIR TOPIC 251: DEVELOPMENT OF ANTICANCER AGENTS REQUESTOR: ALI ANDALIBI VEN

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$185,073.00
Award Year:
2008
Program:
SBIR
Phase:
Phase I
Contract:
N43CM0800027
Agency Tracking Number:
N43CM0800027
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
GENESEGUES, INC.
GENESEGUES, INC., 3180 HIGH POINT DRIVE, CHASKA, MN, 55318
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
095972415
Principal Investigator:
GRETCHEN UNGER
() -
Business Contact:
() -
rtu@genesegues.com
Research Institution:
n/a
Abstract

Metastatic spread of cancer cells is the primary cause of death in cancer patients and developing therapeutic agents that kill primary and disseminated cancer cells is an important topic. The aim of this project is to continue the development of a novel na nocapsule for the delivery of RNAi into tumor cells. Necessary studies to support the filing of an IND will be conducted. Potential off-targeting properties of the nanoencapsulated therapeutic will be investigated in tissue specimens.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government